It looks like your are using Internet Explorer.
Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.
To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
An invite invite link has been sent to you if you do not already have a HealthXL account.
An invite link will be sent to your inbox.
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Join this HealthXL Event today:
Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.
You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.
Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
Participants
Participants
Mirza Ahmed
Senior Director, Hikma Pharmaceuticals
Kevin Darcy
Director, Link Strategy at Veeva Systems
Matt Norton
Vice President of Marketing & Commercial Development at S3 Connected Health
Malin Johansson
Global Head of Digital Health Partnerships at Novo Nordisk
Serdar Gemici
Co-Founder, Albert Health
Ashutosh Malhotra
Digital Business Development & Innovation Scouting Manager Europe at Daiichi Sankyo Europe GmbH
Ralph Morales III
Director, Healthcare Innovation, Oura
Jock Thompson
Chief Revenue Officer, Miku
Valentine Emmanuel
Experience Design & Strategy Lead, Daiichi Sankyo
Ivan Jurisic
Founder/Business Consultant, Patients Influence
Patrick Leyseele
Founder and CEO, 3.life
Tahir Hussain
European BD Director - Digital Therapeutics (DTx), Biofourmis
Carman Ho
Vice President, L1 Health
Up to 12
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
HealthXL Roundtables
HealthXL community meetings connect senior leaders from around the world.
Our virtual Roundtables are small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.
HealthXL community members lead discussion on a defined topic among a maximum of 12 participants. There is no audience and no recordings, just an interactive space to reflect and share learnings.
At 60-minutes long, roundtables are long enough for meaningful discussion among peers, but short enough to fit into busy schedules.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
- Join any virtual and in-person events
- Invite peers to meetings
- Network
- Gain full access to all articles and HealthXL reports
- Get personalised recommendations
- Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
- Full access to community insights and meeting takeaway reports
HealthXL Masterclasses
HealthXL community events give unparalleled access to digital health leaders from around the world.
Our virtual Masterclasses are 60-minute sessions where a recognised expert in their field provides an in-depth learning experience to a small audience of 8-12 members.
HealthXL Masterclasses give you a chance to join a small group of peers and ask questions of recognised experts in a private, convenient setting.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
- Join any virtual and in-person events
- Invite peers to meetings
- Network
- Gain full access to all articles and HealthXL reports
- Get personalised recommendations
- Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
- Full access to community insights and meeting takeaway reports
HealthXL Webinars
HealthXL community events give unparalleled access to digital health experts from around the world.
Our webinars bring together panels of 3-4 global leaders from the HealthXL community to discuss core trends in digital health.
Gain insights on the latest topics in digital health and ask questions of the expert panel via chat. Webinars run for 60 minutes and recordings are shared with all attendees afterwards.
Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:
- Join any virtual and in-person events
- Invite peers to meetings
- Network
- Gain full access to all articles and HealthXL reports
- Get personalised recommendations
- Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
- Full access to community insights and meeting takeaway reports
Join from anywhere
No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.
The world of Digital Health in one Hub
Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers.
As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.
Our community is growing fast. Don’t miss out on your opportunity to lead the future.
News
Your Digital Health Corner
All Posts
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.
All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.
Frequently asked questions:
What are HealthXL Virtual Meetings?
HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
How can I connect with other digital health leaders?
HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.
What are the benefits of being a HealthXL community member?
As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.
Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.
